World Cancer Day: a top priority for Servier
Every year, World Cancer Day takes place on February 4. Initiated by the Union for International Cancer Control (UICC), this day is dedicated to informing and raising the awareness of the general audience about all forms of this deadly disease.
For several years, Servier has been committed to developing treatments for cancers for which therapeutic needs are, for the most part, not yet covered and which are hard to treat, such as digestive, hematologic, and childhood cancers.
The Group’s ambition is to become an innovative player in oncology, by initiating therapeutic progress where the needs are greatest. Over 50% of Servier’s R&D budget is dedicated to this field.
Servier’s oncology R&D programs focus on several approaches: apoptosis, immuno-oncology and cancer cell metabolism.
Learn more with Claude Bertrand, Executive Vice President R&D
Servier is also committed to supporting patients in their fight against cancer by including them at the heart of decision, from research to support beyond medical treatment. Listening to the needs of patients and their families helps the Group to develop more effective therapeutic solutions.
Learn more with Bertrand Renaud, Chief Patient Officer
Close the Care Gap!
Did you know that 90% of low- and middle-income countries do not have access to radiotherapy, one of the essential ways to treat cancer?
That’s why this year’s theme, “Close the Care Gap” aims to raise awareness among all of us about the lack of equity that affects almost everyone, in both high and low-income countries, and costs lives.
Because everyone deserves access to cancer care, Servier is fully supporting this campaign: https://www.worldcancerday.org/fr
Cancer is the second-leading cause of death worldwide (World Health Organization).
10 million people die from cancer every year.
At least one third of common cancers are preventable by implementing resource appropriate strategies for prevention, early detection and treatment.
70% of cancer deaths occur in low-to-middle income countries.
The total annual economic cost of cancer is estimated at US$1.16 trillion.